When drugs are pulled from pharmacy shelves, it’s somewhat of a well-kept secret that it is the pharmaceutical company that voluntarily warns buyers of the potential harm from the defect.
A new trade policy isn’t just emerging; it’s emerged. Six years after former President Donald Trump and his chief trade diplomat Robert Lighthizer imposed tariffs on nearly $400 billion worth of imported goods from China, President Biden has done the same.
We welcome the recent action by DHS to place 26 more Chinese textile companies on the UFLPA Entity List. However, more needs to be done to ensure that Chinese forced labor imports are not skirting the enforcement of U.S. law.
Today’s announcement is a welcome signal step by the Biden administration that it recognizes the importance of supporting America’s solar manufacturing industry and that a whole-of-government approach is needed to counter China’s actions to dominate the global solar supply chain.
In six short years, there is now a strong, bipartisan consensus that trade with China is a serious issue that is harming our nation, workers, and producers.
Mexico may be an ally of the United States, but lately, it hasn’t been behaving like one. Not only is Mexico helping China avoid U.S. tariffs, but it’s also openly violating an agreement not to flood the U.S. with steel products.
A below-expectations jobs report and a continuing decline in the JQI are not good
signs for the U.S. economy.
Generic drug exporter Zydus Lifesciences received poor marks again in April following a Food and Drug Administration inspection of its lab in Vadodara, a city in Gujarat state on India’s western coast.
Why does SEIA oppose tariffs on Chinese solar companies? Because it’s a front for slave labor Chinese solar manufacturers.
CPA strongly supported a previous AD/CVD case filed by Auxin Solar where the Commerce Department determined that Chinese companies operating in Malaysia, Thailand, Vietnam, and Cambodia are illegally circumventing.
